{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:39:11Z","timestamp":1792402751698,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s13312-011-0098-6","type":"journal-article","created":{"date-parts":[[2011,9,30]],"date-time":"2011-09-30T16:48:50Z","timestamp":1317401330000},"page":"627-632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Rituximab"],"prefix":"10.1007","volume":"48","author":[{"given":"Anupama","family":"Borker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,1]]},"reference":[{"key":"98_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3324\/haematol.2008.001628","volume":"95","author":"S.H. Lim","year":"2010","unstructured":"Lim SH, Beers SA, French RR, Johnson PW, Glennie MJ, Cragg MS. Anti-CD20 monoclonal antibodies \u2014 historical and future perspectives. Haematologica. 2010;95:135\u2013143.","journal-title":"Haematologica"},{"key":"98_CR2","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1136\/ard.2006.067124","volume":"66","author":"K.P. Ng","year":"2007","unstructured":"Ng KP, Cambridge G, Leandro MJ, Edwards JC, Ehrenstein M, Isenberg DA. B cell depletion therapy in systemic lupus erythematosus: long-term follow-up and predictors of response. Ann Rheum Dis. 2007;66:1259\u20131262.","journal-title":"Ann Rheum Dis"},{"key":"98_CR3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/j.1432-2277.2006.00345.x","volume":"19","author":"Y.T. Becker","year":"2006","unstructured":"Becker YT, Samaniego-Picota M, Sollinger HW. The emerging role of rituximab in organ transplantation. Transpl Int. 2006;19:621\u2013628.","journal-title":"Transpl Int"},{"key":"98_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/MOP.0b013e3282f424b0","volume":"20","author":"D. Attiasa","year":"2008","unstructured":"Attiasa D, Weitzmanb S. The efficacy of rituximab in highgrade pediatric B-cell lymphoma\/leukemia: a review of available evidence. Curr Opin Pediatr. 2008;20:17\u201322.","journal-title":"Curr Opin Pediatr"},{"key":"98_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/pbc.21753","volume":"52","author":"T.C. Griffin","year":"2009","unstructured":"Griffin TC, Weitzman S, Weinstein H, Chang M, Cairo M, Hutchison R, et al. A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent\/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: report from the Children\u2019s Oncology Group. Pediatr Blood Cancer. 2009;52:177\u2013181.","journal-title":"Pediatr Blood Cancer"},{"key":"98_CR6","first-page":"838","volume":"112","author":"M.S. Cairo","year":"2008","unstructured":"Cairo MS, Lynch J, Harrison L, Van de ven C, Gross T, Shiramizu B, et al. Safety, efficacy and rituximab levels following chemoimmunotherapy (rituximab + FAB chemotherapy) in children and adolescents with mature Bcell Non-Hodgkin lymphoma (B-NHL): a Children\u2019s Oncology Group report. Blood (ASH Meeting Abstracts). 2008;112:838.","journal-title":"Blood (ASH Meeting Abstracts)"},{"key":"98_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1182\/blood.V101.2.420","volume":"101","author":"U. Rehwald","year":"2003","unstructured":"Rehwald U, Schulz H, Reiser M, Sieber M, Staak JO, Morschhauser F, et al. Treatment of relapsed CD 20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group. Blood. 2003;101:420\u2013424.","journal-title":"Blood"},{"key":"98_CR8","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1182\/blood-2002-08-2644","volume":"101","author":"B.C. Ekstrand","year":"2003","unstructured":"Ekstrand BC, Lucas JB, Horwitz SM, Fan Z, Breslin S, Hoppe RT, et al. Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial. Blood. 2003;101:4285\u20134289.","journal-title":"Blood"},{"key":"98_CR9","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1182\/blood-2005-08-3518","volume":"107","author":"C.M. Bennett","year":"2006","unstructured":"Bennett CM, Rogers ZR, Kinnamon DD, Bussel JB, Mahoney DH, Abshire TC, et al. Prospective phase 1\/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. Blood. 2006;107:2639\u20132642.","journal-title":"Blood"},{"key":"98_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/pbc.21166","volume":"49","author":"M. Franchini","year":"2007","unstructured":"Franchini M, Zaffenello M, Veneri D, Lippi G. Rituximab for the treatment of childhood chronic idiopathic thrombocytopenic purpura and hemophilia with inhibitors. Pediatr Blood Cancer. 2007;49:6\u201310.","journal-title":"Pediatr Blood Cancer"},{"key":"98_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/pbc.21757","volume":"52","author":"B.U. Mueller","year":"2009","unstructured":"Mueller BU, Bennett CM, Feldman HA, Bussel JB, Abshire TC, Moore TB, et al. One year follow-up of children and adolescents with chronic immune thrombocytopenia treated with rituximab. Pediatr Blood Cancer. 2009;52:259\u2013262.","journal-title":"Pediatr Blood Cancer"},{"key":"98_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","volume":"115","author":"D. Provan","year":"2010","unstructured":"Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168\u2013186.","journal-title":"Blood"},{"key":"98_CR13","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1182\/blood-2002-11-3547","volume":"101","author":"M. Zecca","year":"2003","unstructured":"Zecca M, Nobili B, Ramenghi U, Perrotta S, Amendola G, Rosito P, et al. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood. 2003;101:3857\u20133861.","journal-title":"Blood"},{"key":"98_CR14","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jpeds.2006.12.038","volume":"150","author":"L.B. Giulino","year":"2007","unstructured":"Giulino LB, Bussel JB, Neufeld EJ; Pediatric and Platelet Immunology Committees of the TMH Clinical Trial Network. Treatment with Rituximab in benign and malignant hematologic disorders in children. J Pediatr. 2007;150:338\u2013344.","journal-title":"J Pediatr"},{"key":"98_CR15","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3324\/haematol.11540","volume":"92","author":"B. Bader-Meunier","year":"2007","unstructured":"Bader-Meunier B, Aladjidi N, Bellmann F, Monpoux F, Nelken B, Robert A, et al. Rituximab therapy for childhood Evan\u2019s syndrome. Haematologica. 2007;92:1691\u20131694.","journal-title":"Haematologica"},{"key":"98_CR16","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1542\/peds.2008-2361","volume":"123","author":"S. Kumar","year":"2009","unstructured":"Kumar S, Benseler SM, Kirby-Allen M, Silverman ED. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus. Pediatrics. 2009;123:e159\u2013e163.","journal-title":"Pediatrics"},{"key":"98_CR17","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/pbc.21965","volume":"52","author":"V.K. Rao","year":"2009","unstructured":"Rao VK, Price S, Perkins K, Aldridge P, Tretler J, Davis J, et al. Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS). Pediatr Blood Cancer. 2009;52:847\u2013852.","journal-title":"Pediatr Blood Cancer"},{"key":"98_CR18","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1538-7836.2009.03332.x","volume":"7","author":"P.W. Collins","year":"2009","unstructured":"Collins PW, Mathias M, Hanley J, Keeling D, Keenan R, Laffan M, et al. Rituximab and immune tolerance in severe hemophilia A: a consecutive national cohort. J Thromb Haemost. 2009;7:787\u2013794.","journal-title":"J Thromb Haemost"},{"key":"98_CR19","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/rheumatology\/kep148","volume":"48","author":"D. Eleftheriou","year":"2009","unstructured":"Eleftheriou D, Melo M, Marks SD, Tullus K, Sills J, Cleary G, et al. Biologic therapy in primary systemic vasculitis of the young. Rheumatology (Oxford). 2009;48:978\u2013986.","journal-title":"Rheumatology (Oxford)"},{"key":"98_CR20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jpeds.2006.01.041","volume":"148","author":"M. Willems","year":"2006","unstructured":"Willems M, Haddad E, Niaudet P, Kon\u00e9-Paut I, Bensman A, Cochat P, et al. French Pediatric-Onset SLE Study Group. Rituximab therapy for childhood-onset systemic lupus erythematosus. J Pediatr. 2006;148:623\u2013627.","journal-title":"J Pediatr"},{"key":"98_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00467-007-0694-9","volume":"23","author":"O. Nwobi","year":"2008","unstructured":"Nwobi O, Abitbol CL, Chandar J, Seeherunvong W, Zilleruelo G. Rituximab therapy for juvenile-onset systemic lupus erythematosus. Pediatr Nephrol. 2008;23:413\u2013419.","journal-title":"Pediatr Nephrol"},{"key":"98_CR22","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s00467-008-0814-1","volume":"23","author":"V. Guigonis","year":"2008","unstructured":"Guigonis V, Dallochio A, Bauduoin V, Dehenault M, Camus CH, Afanetti M, et al. Rituximab treatment for severe steroid or cyclosporine dependant nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol. 2008;23:1269\u20131279.","journal-title":"Pediatr Nephrol"},{"key":"98_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00467-007-0640-x","volume":"23","author":"M. Nakayama","year":"2008","unstructured":"Nakayama M, Kamei K, Nozu K, Matsouka K, Nakagawa, Sako M, et al. Rituximab for refractory focal segmental glomerulosclerosis. Pediatr Nephrol. 2008;23:481\u2013485.","journal-title":"Pediatr Nephrol"},{"key":"98_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/01.mph.0000212991.64435.f0","volume":"28","author":"M.R. Pranzatelli","year":"2006","unstructured":"Pranzatelli MR, Tate DE, Travelstead AL, Barbosa J, Bergamini RA, Civitello L, et al. Rituximab (anti CD20) adjunctive therapy for opsoclonus-myoclonus syndrome. J Pediatr Hematol Oncol. 2006;28:585\u2013593.","journal-title":"J Pediatr Hematol Oncol"},{"key":"98_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1399-3046.2009.01181.x","volume":"14","author":"S. Gallego","year":"2010","unstructured":"Gallego S, Llort A, Gros L, Sanchez de Toledo Jr J, Bueno J, Moreno A, et al. Post-transplant lymphoproliferative disorders in children: The role of chemotherapy in the era of rituximab. Pediatr Transplant. 2010;14:61\u201366.","journal-title":"Pediatr Transplant"},{"key":"98_CR26","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1111\/j.1600-6143.2008.02411.x","volume":"8","author":"V. Zarkhin","year":"2008","unstructured":"Zarkhin V, Li L, Kambham N, Sigdel T, Salvatierra O, Sarwal MM. A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation. Am J Transpl. 2008;8:2607\u20132617.","journal-title":"Am J Transpl"},{"key":"98_CR27","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1097\/TP.0b013e3181880b35","volume":"86","author":"H. Billing","year":"2008","unstructured":"Billing H, Rieger S, Ovens J, S\u00fcsal C, Melk A, Waldherr R, et al. Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients. Transplantation. 2008;86:1214\u20131221.","journal-title":"Transplantation"},{"key":"98_CR28","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","volume":"113","author":"K.R. Carson","year":"2009","unstructured":"Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. 2009;113:4834\u20134840.","journal-title":"Blood."}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-011-0098-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13312-011-0098-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-011-0098-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-011-0098-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T01:58:11Z","timestamp":1744163891000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13312-011-0098-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["98"],"URL":"https:\/\/doi.org\/10.1007\/s13312-011-0098-6","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"value":"0019-6061","type":"print"},{"value":"0974-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"1 October 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}